A trial of AsiDNA monotherapy via systemic administration

Trial Profile

A trial of AsiDNA monotherapy via systemic administration

Planning
Phase of Trial: Phase I

Latest Information Update: 05 Jul 2017

At a glance

  • Drugs AsiDNA (Primary)
  • Indications Cancer
  • Focus Adverse reactions
  • Sponsors Onxeo SA
  • Most Recent Events

    • 05 Jul 2017 According to an Onxeo SA media release, the company intends to file the phase I trial submission dossier to regulatory authorities by the end of 2017.
    • 26 Apr 2017 Planned initiation date changed from 1 Jan 2017 to 1 Dec 2017, according to an Onxeo SA media release.
    • 26 Apr 2017 According to an Onxeo SA media release, the company expects to initiate this study by the end of 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top